Clinical Validation Study for iVue
Completed
- Conditions
- Normal and Ocular Pathology
- Registration Number
- NCT01242553
- Lead Sponsor
- Optovue
- Brief Summary
To demonstrate clinical substantial equivalence of iVue as comparable to commercially available RTVue.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
- Normal: Normal results from clinical exam and free of ocular pathology.
- Glaucoma: Clinical exam results consistent with glaucoma and visual field defects consistent with glaucoma.
- Cornea: Clinical exam results consistent with cornea pathology.
- Retina: Clinical exam results consistent with retina pathology
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method thickness of ocular structures
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie iVue's performance in ocular pathology detection compared to RTVue?
How does iVue's imaging technology compare to standard-of-care OCT devices in detecting retinal diseases?
Are there specific biomarkers that correlate with iVue's diagnostic accuracy in ocular conditions?
What adverse events were reported in iVue clinical trials and how were they managed?
How does Optovue's iVue compare to other OCT technologies like Cirrus HD-OCT in clinical validation studies?
Trial Locations
- Locations (2)
Pacific Eye Specialists
🇺🇸Daly City, California, United States
Colorado Retina Center
🇺🇸Denver, Colorado, United States
Pacific Eye Specialists🇺🇸Daly City, California, United States